Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity used in treating tumors, immune system disorders, and blood and lymphatic system disorders. Additionally, Edralbrutinib is studied for its efficacy in membranous glomerulonephritis and optic neuromyelitis optica.
Molecular Weight:
489.47
Purity:
99.47%
CAS Number:
[1858206-58-2]
Formula:
C26H21F2N5O3
Target:
BTK
T63272
* VAT and and shipping costs not included. Errors and price changes excepted